pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Spontaneous Urticaria, Asthma, Systemic Lupus Erythematosus, Breast Cancer, Multiple Sclerosis. NovaP
Mumbai, IN HQ
1996 Founded
2,240 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
OAV101
Phase 3 · gene therapy · Spinal Muscular Atrophy
OAV101 for Spinal Muscular Atrophy is a Phase 3 program (gene_therapy) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code COAV101B12302
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 3
- Modality
- gene_therapy
- Indication
- Spinal Muscular Atrophy
- Status
- completed
- Trials
- 1